OXiGENE (NASDAQ:OXGN)‘s stock had its “buy” rating reissued by Zacks in a research note issued to investors on Friday May 1st.
Separately, analysts at MLV & Co. set a $6.50 price target on shares of OXiGENE and gave the company a “buy” rating in a research note on Wednesday, March 18th.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.